Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00395993 · ClinicalTrials.gov registry record · Phase 3
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
A Phase 3 study, sponsored by American Regent.
- Completed
- Registry status
- Phase 3
- Development phase
- 456
- Enrollment target
NCT00395993 is a Phase 3 study that has completed, run by American Regent. The registered enrollment target is 456 participants.
The verdict
NCT00395993, a Phase 3 study, has completed, sponsored by American Regent.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 456 participants
- Enrollment target
Study Summary
This study compares of the safety and efficacy of intravenous iron vs oral iron in the treatment of anemia secondary to heavy uterine bleeding
Interventions
- DRUG Ferric Carboxymaltose (FCM)
- DRUG Ferrous Sulfate tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 456 participants |
| Start Date | 2005-05 |
| Est. Completion | 2006-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00395993
The ClinicalTrials.gov registry entry for NCT00395993 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 456 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Regent, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ferric Carboxymaltose (FCM) is the first listed.
NCT00395993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00395993 about?
NCT00395993 is a clinical study titled "Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding". This study compares of the safety and efficacy of intravenous iron vs oral iron in the treatment of anemia secondary to heavy uterine bleeding
What is the current status of trial NCT00395993?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 456 participants. The study started on 2005-05. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00395993?
The interventions under investigation include: Ferric Carboxymaltose (FCM) (DRUG), Ferrous Sulfate tablets (DRUG).
Who is sponsoring clinical trial NCT00395993?
This trial is sponsored by American Regent, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.